본문

  1. Home
9 Results:AA:GLORIEUX F H 0.46 sec.
RSS 
Multilingual
 Расширенный поиск
 Новый поиск книги прибытия
Selected Print Select Export to Excel
1
Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Christof Land,, | Elsevier Inc | 2007 ,
2
Intracortical remodeling during human bone development—A histomorphometric study
Intracortical remodeling during human bone development—A histomorphometric study
Rauch, F., | Elsevier Inc | 2007 ,
3
Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta
Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta
Rauch, F., | Elsevier Inc | 2007 ,
4
High and low density in the same bone: a study on children and adolescents with mild osteogenesis imperfecta
High and low density in the same bone: a study on children and adolescents with mild osteogenesis imperfecta
Rauch, F., | Elsevier Inc | 2005 ,
5
CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII
CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII
Fratzl-Zelman, N., | Elsevier Inc | 2010 ,
6
Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults
Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults
Fratzl-Zelman, N., | Elsevier Inc | 2009 ,
7
Vertebral morphometry in children and adolescents with osteogenesis imperfecta : Effect of intravenous pamidronate treatment
Vertebral morphometry in children and adolescents with osteogenesis imperfecta : Effect of intravenous pamidronate treatment
Christof Land., | Elsevier Inc | 2006 ,
8
Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta
Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta
Markus Weber., | Elsevier Inc | 2006 ,
9
The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfectaType V
The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfectaType V
Leonid Zeitlin., | Elsevier Inc | 2006 ,
처음1마지막